BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 16952554)

  • 41. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier.
    Kong J; Zhang Z; Musch MW; Ning G; Sun J; Hart J; Bissonnette M; Li YC
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G208-16. PubMed ID: 17962355
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium.
    Suzuki K; Sun X; Nagata M; Kawase T; Yamaguchi H; Sukumaran V; Kawauchi Y; Kawachi H; Nishino T; Watanabe K; Yoneyama H; Asakura H
    Pathol Int; 2011 Apr; 61(4):228-38. PubMed ID: 21418395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of adiponectin in colitis.
    Ogunwobi OO; Beales IL
    Gastroenterology; 2007 Mar; 132(3):1199-200; author reply 1200-1. PubMed ID: 17383446
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of mice with dextran sulfate sodium-induced colitis with human interleukin 10 secreted by transformed Bifidobacterium longum.
    Yao J; Wang JY; Lai MG; Li YX; Zhu HM; Shi RY; Mo J; Xun AY; Jia CH; Feng JL; Wang LS; Zeng WS; Liu L
    Mol Pharm; 2011 Apr; 8(2):488-97. PubMed ID: 21271712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rosuvastatin, a new HMG-CoA reductase inhibitor, reduces the colonic inflammatory response in dextran sulfate sodium-induced colitis in mice.
    Naito Y; Katada K; Takagi T; Tsuboi H; Isozaki Y; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    Int J Mol Med; 2006 Jun; 17(6):997-1004. PubMed ID: 16685407
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aggravation of intestinal inflammation by depletion/deficiency of gammadelta T cells in different types of IBD animal models.
    Kühl AA; Pawlowski NN; Grollich K; Loddenkemper C; Zeitz M; Hoffmann JC
    J Leukoc Biol; 2007 Jan; 81(1):168-75. PubMed ID: 17041003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
    Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
    Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant human granulocyte colony-stimulating factor reduces colonic epithelial cell apoptosis and ameliorates murine dextran sulfate sodium-induced colitis.
    Kudo T; Matsumoto T; Nakamichi I; Yada S; Esaki M; Jo Y; Ohji Y; Yao T; Iida M
    Scand J Gastroenterol; 2008; 43(6):689-97. PubMed ID: 18569986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-1beta targets interleukin-6 in progressing dextran sulfate sodium-induced experimental colitis.
    Kwon KH; Murakami A; Hayashi R; Ohigashi H
    Biochem Biophys Res Commun; 2005 Nov; 337(2):647-54. PubMed ID: 16202978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nrf2-deficient mice have an increased susceptibility to dextran sulfate sodium-induced colitis.
    Khor TO; Huang MT; Kwon KH; Chan JY; Reddy BS; Kong AN
    Cancer Res; 2006 Dec; 66(24):11580-4. PubMed ID: 17178849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omega-3 fatty acids exacerbate DSS-induced colitis through decreased adiponectin in colonic subepithelial myofibroblasts.
    Matsunaga H; Hokari R; Kurihara C; Okada Y; Takebayashi K; Okudaira K; Watanabe C; Komoto S; Nakamura M; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
    Inflamm Bowel Dis; 2008 Oct; 14(10):1348-57. PubMed ID: 18484673
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A role for proteinase-activated receptor-1 in inflammatory bowel diseases.
    Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S
    J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orally administered aqueous extract of Inonotus obliquus ameliorates acute inflammation in dextran sulfate sodium (DSS)-induced colitis in mice.
    Mishra SK; Kang JH; Kim DK; Oh SH; Kim MK
    J Ethnopharmacol; 2012 Sep; 143(2):524-32. PubMed ID: 22819687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
    Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
    Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.
    Castaneda FE; Walia B; Vijay-Kumar M; Patel NR; Roser S; Kolachala VL; Rojas M; Wang L; Oprea G; Garg P; Gewirtz AT; Roman J; Merlin D; Sitaraman SV
    Gastroenterology; 2005 Dec; 129(6):1991-2008. PubMed ID: 16344067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis].
    Wen ZH; Quyang Q; Zhang H; Yi ZH; Wang YF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):676-8. PubMed ID: 16235535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon.
    Vowinkel T; Anthoni C; Wood KC; Stokes KY; Russell J; Gray L; Bharwani S; Senninger N; Alexander JS; Krieglstein CF; Grisham MB; Granger DN
    Gastroenterology; 2007 Mar; 132(3):955-65. PubMed ID: 17324402
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical antisense oligonucleotide therapy against LIX, an enterocyte-expressed CXC chemokine, reduces murine colitis.
    Kwon JH; Keates AC; Anton PM; Botero M; Goldsmith JD; Kelly CP
    Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1075-83. PubMed ID: 16099872
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.
    Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H
    Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.